Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
180 Life Sciences (ATNF)
NASDAQ:ATNF
Holding ATNF?
Track your performance easily
ATNF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $17.75
Previous Close$1.86
Volume54.55K
Average Volume (3M)2.01M
Market Cap
$3.68M
Enterprise Value$3.97M
Total Cash (Recent Filing)$194.92K
Total Debt (Recent Filing)$483.72K
Price to Earnings (P/E)―
Beta1.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.81
Shares Outstanding1,976,999
10 Day Avg. Volume186,369
30 Day Avg. Volume2,008,370
Standard Deviation0.97
R-Squared0.03
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)3.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
180 Life Sciences News
PremiumCompany Announcements
180 Life Sciences CFO Omar Jimenez Resigns
PremiumCompany Announcements
180 Life Sciences Expands Board with Stephen Shoemaker
PremiumCompany Announcements
180 Life Sciences Expands into Online Gaming Sector
Ownership Overview
12.69%
Insiders
0.38% Mutual Funds
0.71% Other Institutional Investors
86.09% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ATNF FAQ
What was 180 Life Sciences’s price range in the past 12 months?
180 Life Sciences lowest stock price was $1.16 and its highest was $17.75 in the past 12 months.
What is 180 Life Sciences’s market cap?
Currently, no data Available
When is 180 Life Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were 180 Life Sciences’s earnings last quarter?
Currently, no data Available
Is 180 Life Sciences overvalued?
According to Wall Street analysts 180 Life Sciences’s price is currently Overvalued.
Does 180 Life Sciences pay dividends?
180 Life Sciences does not currently pay dividends.
What is 180 Life Sciences’s EPS estimate?
180 Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 180 Life Sciences have?
180 Life Sciences has 1,976,999 shares outstanding.
What happened to 180 Life Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of 180 Life Sciences?
Currently, no hedge funds are holding shares in ATNF
---
180 Life Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.69%
12-Months-Change
Fundamentals
Return on Equity
-174.19%
Trailing 12-Months
Asset Growth
111.17%
Trailing 12-Months
Company Description
180 Life Sciences
KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in Newark, DE.
---
Technical Analysis
Anixa Biosciences
―
Eloxx Pharmaceuticals
―
Solid Biosciences
―
BioMarin Pharmaceutical
―
---